Sharon Ehrmeyer, PhD, the regulatory affairs section editor for Point of Care – the journal of near patient testing and technology, answers your questions in CLP’s Expert Insight on lab and POCT testing QC.
Read More
Molecular biology is continuing to revolutionize disease diagnosis. Modern molecular tests based on the detection of nucleic acids (ie, DNA and RNA) offer considerable advantages over traditional methods of pathogen detection.
Read More
The portable device is capable of measuring from 1 to 3 cardiac biomarkers on a single 500-μL whole blood aliquot in approximately 20 minutes.
Read More
Some recommend expanded screening for high-risk individuals to pin down diagnosis earlier.
Read More
Focus is on creating an instrument-free, paper-based, fully-disposable device for use in remote areas where access to medical diagnostic equipment is limited. Goal is to build an easy-to-use device that can detect a wide range of diseases in less tha
Read More